Curaleaf: Setback for a Comeback 🌪️The price of Curaleaf has set back significantly since its impressive rise in September. Soon, however, it should continue, as the price has now reached the green target zone between CAD 5.50 and CAD 4.33, where we locate the low of the green wave 2. Following the low, there should then be significant gains again with the further green five-wave move, reaching CAD 12.
CURA
CURA buystrong rejection of the level after a long red candel
shows the end of the down trend and a possible start
of an uptrend
Curaleaf golden corner pocketPretty had to find a more beautiful chart. Looking for the break of the falling wedge for confirmation.
CURALEAF (OTC) Bullish TargetDAILY CHART
CURA forming a wedge.It can move sideways a bit until next earnings on NOVEMBER 23. November 23rd is near the edge of the wedge, when multi-day breakout can happen.
With the thickest part of the wedge measured, and cloned (see the purple slanted line) it should reach the target of $17.90.
About a 50-60% return from the bottom of the wedge.
Descending Triangle for CURA?Or, possibly this pattern plays out as a bullish flag.
The KST is displaying a bearish cross where I have placed the red downward pointing finger.
Keep an eye on the DMI in the upcoming trading days, if there's a bullish cross it would be very note-worthy for the bullish narrative. Something similar to what happened where I've placed the green fingers.
The share price is nearing the end of the pattern which doesn't happen too often, this could be due to some indecision among market makers and other participants trading / investing in the stock.
The best Canadian gift for youHello traders, this thing is strongly bullish now but its about to curve downward. I see the TOP forming. Get ready for the shorts.
Descending Triangle for CURA?It's possible this pattern plays out bullishly as a Bull Flag, there's a noticeable divergence on the RSI, we've seen higher lows in the RSI but the share price has basically chopped sideways.
On the KST there's been a bearish cross.
Grifols: A new bullish channel up to +18%?Focused on hemoderivatives (blood plasma), Grifols is great value by most of investors. Even though the company might be one day spitted by any scandal on how it is gathering the plasma in the US, americans have got a high stake on it and today it is focusing on an hyperimmune immunoglobulin with specific antibodies against the SARS-CoV-2 virus. Grifols estimated an impact on its accounts of €200 million and many rating houses have downgraded the stock. Its 2019's profits were up 4.8% to 625 million and an EBITDA of 1,434 million (+17,3% YoY). In 2020, Q1 Net profits were up 63% and EBITDA 14.9%. Results on its tests will be presented in July (the mandatory 14 days to see whether the virus is gone or not). We may experience volatility in the price of the company until July 01. According to some news, Grifols' margins were not attractive and that is why the correction of the share price has taken place.
Technically speaking, the company might be immersed in a bullish channel started on March 16 and closing out a triangle started on Feb 20. We could expect the share price go at least up to 29.40 level in the next days. Best price to enter Grifols might be 27€. Also, note that when markets are down, Grifols is up acting like a safe haven asset.
CURA Structural Support| Resistance Confluence| Declining VolumeEvening Traders,
Today’s Technical Analysis – CURA – holding a key support with the current volume clearly declining, a move will be imminent with a subsequent influx.
Points to consider,
- Macro trend bearish
- Resistance confluence
- Structural support being tested
- RSI above 50
- Stochastics projected down
- Declining volume
CURA’s overall trend is bearish with consecutive lower highs, currently recovering from oversold conditions that needs momentum follow through.
There is resistance confluence with the .50 Fibonacci and the 100 EMA; price needs to trade above it to establish a higher high for the local trend to remain true.
Structural support is being tested; current candle closes have been bearish, indicating weakness in the bulls.
The RSI is trading above 50, likely to break if current support does not hold. The stochastics on the other hand is at a key level, if the higher low projection does not hold, the sell cross will increase momentum to the downside.
Volume is declining; technically this leads to an influx at key trade locations.
Overall, in my opinion, CURA needs to hold structural support for a probable higher low. With the declining volume at support, this is an indication of an impulsive move. If support breaks then the macro trend is still intact.
What are your thoughts?
Please leave a like and comment,
And remember,
“Ultimately, consistent profitability comes down to choosing between the discomforts you feel when you follow your plan and the urge to let yourself be captures ( and ruled) by your emotions.” ― Yvan Byeajee
Double Bottom?Is Curaleaf going to shake off the FUD from the FDA & continue crush the U.S market.
I think so, although they may have stepped over some boundaries with promotion / labeling & making claims on some of their cbd products, it doesn't change the position they have in the U.S with distribution.
It looks like CURA may have found a double bottom?
Time will tell per usual.
cura 5july2019 something @cryptoKneeClosed the gap, in the GZ, fibs lininging up, bull DIV... not asking for ATH but some kinda reaction would be awesome! Never know.
cura update 17jun2019 @cryptoKneeReaction! The PA is not quite in the fib projection for a fif so 1 more leg down would not surprise.
curlf 07jun2019 @cryptoKneemaybe one of these 3,... but I aint Marty Mcfly... Im Marty McHigh!!!!!!!
Second pennant on CURA - Possible breakout MondayCURA is a the Cannacord conference Monday. Could be a good news release and a 10% day.
